Publications by authors named "Mark Allan"

Claim this Profile
C
Characterization of Ebola Virus Risk to Bedside Providers in an Intensive Care Environment.
Mia J Biondi, Lauren Garnett, Alexander Bello, Duane Funk, Philippe Guillaume Poliquin, Mark Allan

Microorganisms· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Impact of intensive care unit supportive care on the physiology of Ebola virus disease in a universally lethal non-human primate model.
Guillaume Poliquin, Duane Funk, Shane Jones, Kaylie Tran, Charlene Ranadheera, Mark Allan

Intensive Care Med Exp· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of intensive care unit supportive care on the physiology of Ebola virus disease in a universally lethal non-human primate model.
Guillaume Poliquin, Duane Funk, Shane Jones, Kaylie Tran, Charlene Ranadheera, Mark Allan

Intensive Care Med Exp· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivering Prolonged Intensive Care to a Non-human Primate: A High Fidelity Animal Model of Critical Illness.
P Guillaume Poliquin, Mia Biondi, Charlene Ranadheera, Mable Hagan, Alexander Bello, Mark Allan

Sci Rep· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of concurrent treatment of cats with fluralaner and emodepsid-praziquantel.
Feli M Walther, Mark J Allan, Rainer K A Roepke

Parasit Vectors· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Safety of concurrent treatment of cats with fluralaner and emodepsid-praziquantel.
Feli M Walther, Mark J Allan, Rainer K A Roepke

Parasit Vectors· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative pharmacokinetics of fluralaner in dogs and cats following single topical or intravenous administration.
Susanne Kilp, Diana Ramirez, Mark J Allan, Rainer Ka Roepke

Parasit Vectors· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs.
Feli M Walther, Mark J Allan, Rainer K A Roepke

Parasit Vectors· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceleration of genetic gain in cattle by reduction of generation interval.
Poothappillai Kasinathan, Hong Wei, Tianhao Xiang, Jose A Molina, John Metzger, Mark F Allan

Sci Rep· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of concurrent treatment of dogs with fluralaner (Bravecto™) and milbemycin oxime-praziquantel.
Feli M Walther, Petr Fisara, Mark J Allan, Rainer K A Roepke, Martin C Nuernberger

Parasit Vectors· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of food on the pharmacokinetics of oral fluralaner in dogs.
Feli M Walther, Mark J Allan, Rainer K A Roepke, Martin C Nuernberger

Parasit Vectors· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration.
Feli M Walther, Allan J Paul, Mark J Allan, Rainer K A Roepke, Martin C Nuernberger

Parasit Vectors· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration.
Susanne Kilp, Diana Ramirez, Mark J Allan, Rainer K A Roepke, Martin C Nuernberger

Parasit Vectors· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of fluralaner chewable tablets (Bravecto), a novel systemic antiparasitic drug, in dogs after oral administration.
Feli M Walther, Mark J Allan, Rainer K A Roepke, Martin C Nuernberger

Parasit Vectors· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of the concurrent treatment of dogs with Bravecto (fluralaner) and Scalibor protectorband (deltamethrin).
Feli M Walther, Petr Fisara, Mark J Allan, Rainer K A Roepke, Martin C Nuernberger

Parasit Vectors· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teleneonatology: a major tool for the future.
Stephen Minton, Mark Allan, Wesley Valdes

Pediatr Ann· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inferring genetic architecture of complex traits using Bayesian integrative analysis of genome and transcriptome data.
Alireza Ehsani, Peter Sørensen, Daniel Pomp, Mark Allan, Luc Janss

BMC Genomics· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-tissue coexpression networks reveal unexpected subnetworks associated with disease.
Radu Dobrin, Jun Zhu, Cliona Molony, Carmen Argman, Mark L Parrish, Mark F Allan

Genome Biol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of a high density SNP genotyping assay for cattle.
Lakshmi K Matukumalli, Cynthia T Lawley, Robert D Schnabel, Jeremy F Taylor, Mark F Allan

PLoS One· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer incidence in the Middle Eastern population of California, 1988-2004.
Kiumarss Nasseri, Paul K Mills, Mark Allan

Asian Pac J Cancer Prev· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic mapping of direct and correlated responses to long-term selection for rapid growth rate in mice.
Mark F Allan, Eugene J Eisen, Daniel Pomp

Genetics· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The M16 mouse: an outbred animal model of early onset polygenic obesity and diabesity.
Mark F Allan, Eugene J Eisen, Daniel Pomp

Obes Res· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast lithium ion diffusion in the ternary layered nitridometalate LiNiN.
Zlatka Stoeva, Ruben Gomez, Alexandra G Gordon, Mark Allan, Duncan H Gregory

J Am Chem Soc· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of hypothalamic gene expression in mice divergently selected for heat loss.
Stephanie R Wesolowski, Mark F Allan, Merlyn K Nielsen, Daniel Pomp

Physiol Genomics· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential expression of NAT1 translational repressor during development of bovine intramuscular adipocytes.
Kirby D Childs, David W Goad, Mark F Allan, Daniel Pomp, Clinton Krehbiel

Physiol Genomics· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis